Literature DB >> 16302988

13C-urea breath test to assess Helicobacter pylori bacterial load.

Rocco Maurizio Zagari1, Paolo Pozzato, Cristina Martuzzi, Lorenzo Fuccio, Giuseppe Martinelli, Enrico Roda, Franco Bazzoli.   

Abstract

BACKGROUND: Some authors have reported, using different protocols, that 13C-urea breath test (13C-UBT) is capable of assessing the intragastric Helicobacter pylori bacterial load, whereas others have not confirmed these data. Our aim is to evaluate the correlation between 13C-UBT values and H. pylori bacterial load.
MATERIALS AND METHODS: One hundred ninety-two patients diagnosed H. pylori-positive by rapid urease test, histology, and 13C-UBT were enrolled. H. pylori bacterial load (H. pylori score) and gastritis activity (activity score) were evaluated according to the Updated Sydney System. 13C-UBT was performed according to the European Standard Protocol. Breath samples were obtained every 10 minutes for 60 minutes in 52 patients and at 30 minutes (T30) in 140 patients and analyzed by mass spectrometry.
RESULTS: At T30, mean +/- SD excess delta 13CO2 excretion was 17.4 +/- 1.1, 29.9 +/- 2.2, and 48.7 +/- 4.8 in patients with H. pylori scores 1, 2, and 3, respectively. This difference was statistically significant: H. pylori score 1 versus 2, p < .005; score 1 versus 3, p < .05; score 2 versus 3, p < .05. A significant positive correlation (G = 0.59) was found between H. pylori score and activity score of chronic gastritis. At T40 and T50 significant correlation between mean excess delta 13CO2 excretion and bacterial load was achieved only in patients with H. pylori scores 1 and 3.
CONCLUSIONS: 13C-UBT European Standard Protocol values correlate with H. pylori bacterial load and the activity of gastritis at T30 breath sampling time.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16302988     DOI: 10.1111/j.1523-5378.2005.00358.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  17 in total

1.  Diagnostic accuracy of tests for Helicobacter pylori in an Alaska Native population.

Authors:  Dana L Bruden; Michael G Bruce; Karen M Miernyk; Julie Morris; Debby Hurlburt; Thomas W Hennessy; Helen Peters; Frank Sacco; Alan J Parkinson; Brian J McMahon
Journal:  World J Gastroenterol       Date:  2011-11-14       Impact factor: 5.742

Review 2.  Diagnosis of Helicobacter pylori: what should be the gold standard?

Authors:  Saurabh Kumar Patel; Chandra Bhan Pratap; Ashok Kumar Jain; Anil Kumar Gulati; Gopal Nath
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

3.  Novel CagA ELISA exhibits enhanced sensitivity of Helicobacter pylori CagA antibody.

Authors:  Yuichi Matsuo; Yasutoshi Kido; Junko Akada; Seiji Shiota; Tran Thanh Binh; Tran Thi Huyen Trang; Ho D Q Dung; Pham Huu Tung; Tran Dinh Tri; Ngo P Minh Thuan; Le Quang Tam; Bui Chi Nam; Vu Van Khien; Yoshio Yamaoka
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

4.  13C-urea breath test values and Helicobacter pylori eradication.

Authors:  Angelo Zullo; Federico Perna; Chiara Ricci; Cesare Hassan; Andrea Tampieri; Vincenzo De Francesco; Sergio Morini; Dino Vaira
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

5.  Interpretation of the 13C-urea breath test in the choice of second- and third-line eradication of Helicobacter pylori infection.

Authors:  György M Buzás; Ilona Széles
Journal:  J Gastroenterol       Date:  2008-02-29       Impact factor: 7.527

6.  Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy.

Authors:  Veronica Ojetti; Giovanni Bruno; Maria Elena Ainora; Giovanni Gigante; Gianluca Rizzo; Davide Roccarina; Antonio Gasbarrini
Journal:  Gastroenterol Res Pract       Date:  2012-05-29       Impact factor: 2.260

7.  Effect of GutGard in the Management of Helicobacter pylori: A Randomized Double Blind Placebo Controlled Study.

Authors:  Sreenivasulu Puram; Hyung Chae Suh; Seung Un Kim; Bharathi Bethapudi; Joshua Allan Joseph; Amit Agarwal; Venkateswarlu Kudiganti
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-27       Impact factor: 2.629

8.  Non-viable Lactobacillus reuteri DSMZ 17648 (Pylopass™) as a new approach to Helicobacter pylori control in humans.

Authors:  Heidrun Mehling; Andreas Busjahn
Journal:  Nutrients       Date:  2013-08-02       Impact factor: 5.717

Review 9.  Non-invasive diagnostic tests for Helicobacter pylori infection.

Authors:  Lawrence Mj Best; Yemisi Takwoingi; Sulman Siddique; Abiram Selladurai; Akash Gandhi; Benjamin Low; Mohammad Yaghoobi; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15

10.  Comparison of the 13C-urea breath test and the endoscopic phenol red mucosal pH test in the quantification of Helicobacter pylori infection loading.

Authors:  Young-Seok Cho; Hiun-Suk Chae; Se Na Jang; Jin-Soo Kim; Hye Suk Son; Hyung-Keun Kim; Byung-Wook Kim; Sok-Won Han; Kyu-Yong Choi; Hae Kyung Lee; Eun Deok Chang
Journal:  Korean J Intern Med       Date:  2008-09       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.